Systemic and endocrine manifestations of Langerhans’ cell histiocytosis: current concepts in diagnosis and management

References

• Favara BE. Langerhans’ cell histiocytosis pathobiology and pathogenesis. Semin. Oncol.18(1), 3–7 (1991).
   PubMed Web of Science ®Google Scholar
• Arceci RJ. The histiocytoses: the fall of the Tower of Babel. Eur. J. Cancer35(5), 747–767 (1999).
   PubMed Web of Science ®Google Scholar
• Weitzman S, Egeler RM. Histiocytic Disorders of Children and Adults Basic Science, Clinical Features and Therapy. Cambridge University Press, Cambridge, UK (2006).
   Google Scholar
• Coppes-Zantinga A, Egeler RM. The Langerhans cell histiocytosis X files revealed. Br. J. Haematol.116(1), 3–9 (2002).
   Web of Science ®Google Scholar
• Mittheisz E, Seidl R, Prayer D et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr. Blood Cancer48(1), 50–56 (2007).
   Google Scholar
• Haupt R, Nanduri V, Calevo MG et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr. Blood Cancer42(5), 438–444 (2004).
   PubMed Web of Science ®Google Scholar
• Broadbent V, Egeler RM, Nesbit ME Jr. Langerhans cell histiocytosis – clinical and epidemiological aspects. Br. J. Cancer23(Suppl.), S11–S16 (1994).
   Google Scholar
• Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med. Pediatr. Oncol.28(1), 9–14 (1997).
   PubMedGoogle Scholar
• Malpas JS. Langerhans cell histiocytosis in adults. Hematol. Oncol. Clin. North Am.12(2), 259–268 (1998).
   Google Scholar
• Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet343(8900), 767–768 (1994).
   PubMed Web of Science ®Google Scholar
• Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am. J. Surg. Pathol.25(5), 630–636 (2001).
   PubMed Web of Science ®Google Scholar
• Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N. Engl. J. Med.346(7), 484–490 (2002).
   PubMed Web of Science ®Google Scholar
• Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood94(12), 4195–4201 (1999).
   PubMed Web of Science ®Google Scholar
• Egeler RM, Favara BE, Laman JD, Claassen E. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur. J. Cancer36(16), 2105–2110 (2000).
   Google Scholar
• Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PC, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J. Exp. Med.197(10), 1385–1390 (2003).
   PubMed Web of Science ®Google Scholar
• De Filippi P, Badulli C, Cuccia M et al. Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br. J. Haematol.132(6), 784–787 (2006).
   Google Scholar
• Rosso DA, Roy A, Zelazko M, Braier JL. Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis. Br. J. Haematol.117(1), 54–58 (2002).
   Google Scholar
• Rolland A, Guyon L, Gill M et al. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J. Immunol.174(5), 3067–3071 (2005).
   PubMedGoogle Scholar
• Prosch H, Grois N, Bokkerink J et al. Central diabetes insipidus: is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall. Pediatr. Blood Cancer46(3), 363–366 (2006).
   Google Scholar
• Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med. Pediatr. Oncol.29(3), 157–166 (1997).
   PubMedGoogle Scholar
• Chu T, D’Angio GJ, Favara BE, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet2(8549), 41–42 (1987).
   PubMedGoogle Scholar
• Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol. Metab.18(6), 252–257 (2007).
   Google Scholar
• LCH-A1. First International Study for Langerhans Cell Histiocytosis in Adults. Histiocyte Society (2004).
   Google Scholar
• Ceci A, de Terlizzi M, Colella R et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X ‘83 study. Med. Pediatr. Oncol.21(4), 259–264 (1993).
   PubMedGoogle Scholar
• Gadner H, Grois N, Arico M et al. A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J. Pediatr.138(5), 728–734 (2001).
   PubMed Web of Science ®Google Scholar
• Donadieu J, Piguet C, Bernard F et al. A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr. Blood Cancer43(7), 770–776 (2004).
   PubMed Web of Science ®Google Scholar
• Arico M, Girschikofsky M, Genereau T et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur. J. Cancer39(16), 2341–2348 (2003).
   PubMed Web of Science ®Google Scholar
• Amato MC, Elias LL, Elias J et al. Endocrine disorders in pediatric-onset Langerhans cell histiocytosis. Horm. Metab. Res.38(11), 746–751 (2006).
   Google Scholar
• Dunger DB, Broadbent V, Yeoman E et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N. Engl. J. Med.321(17), 1157–1162 (1989).
   PubMedGoogle Scholar
• Jubinsky PT. Hypercalcemia in Langerhans cell histiocytosis: is it therapy-related? J. Pediatr. Hematol. Oncol.25(2), 176–179 (2003).
   Google Scholar
• Arenzana-Seisdedos F, Barbey S, Virelizier JL, Kornprobst M, Nezelof C. Histiocytosis X purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J. Clin. Invest.77(1), 326–329 (1986).
   PubMed Web of Science ®Google Scholar
• Dalle CL, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J. Bone Miner. Res.16(1), 97–103 (2001).
   PubMed Web of Science ®Google Scholar
• Wuster C, Abs R, Bengtsson BA et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Miner. Res.16(2), 398–405 (2001).
   PubMed Web of Science ®Google Scholar
• Crone-Munzebrock W, Brassow F. A comparison of radiographic and bone scan findings in histiocytosis X. Skeletal Radiol.9(3), 170–173 (1983).
   Google Scholar
• Jubran RF, Marachelian A, Dorey F, Malogolowkin M. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr. Blood Cancer45(1), 37–42 (2005).
   PubMed Web of Science ®Google Scholar
• Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: report of 30 cases. Pediatr. Dev. Pathol.5(2), 130–140 (2002).
   PubMed Web of Science ®Google Scholar
• Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol. Oncol. Clin. North Am.12(2), 269–286 (1998).
   PubMed Web of Science ®Google Scholar
• Nondahl SR, Finlay JL, Farrell PM, Warner TF, Hong R. A case report and literature review of ‘primary’ pulmonary histiocytosis X of childhood. Med. Pediatr. Oncol.14(1), 57–62 (1986).
   Google Scholar
• Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans’-cell histiocytosis. N. Engl. J. Med.342(26), 1969–1978 (2000).
   PubMedGoogle Scholar
• Braier J, Ciocca M, Latella A, de Davila MG, Drajer M, Imventarza O. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell histiocytosis. Med. Pediatr. Oncol.38(3), 178–182 (2002).
   Google Scholar
• Griffiths W, Davies S, Gibbs P, Thillainayagam A, Alexander G. Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosis. J. Hepatol.44(4), 829–831 (2006).
   Google Scholar
• Siegal GP, Dehner LP, Rosai J. Histiocytosis X (Langerhans’ cell granulomatosis) of the thymus. A clinicopathologic study of four childhood cases. Am. J. Surg. Pathol.9(2), 117–124 (1985).
   Google Scholar
• Osband ME, Lipton JM, Lavin P et al. Histiocytosis-X. N. Engl. J. Med.304(3), 146–153 (1981).
   PubMed Web of Science ®Google Scholar
• Irving RM, Broadbent V, Jones NS. Langerhans’ cell histiocytosis in childhood: management of head and neck manifestations. Laryngoscope104(1 Pt 1), 64–70 (1994).
   PubMed Web of Science ®Google Scholar
• Grois N, Tsunematsu Y, Barkovich AJ, Favara BE. Central nervous system disease in Langerhans cell histiocytosis. Br. J. Cancer Suppl.23, S24–S28 (1994).
   Google Scholar
• Grois N, Prayer D, Prosch H, Lassmann H. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain128(Pt 4), 829–838 (2005).
   Google Scholar
• Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am. J. Neuroradiol.25(5), 880–891 (2004).
   PubMed Web of Science ®Google Scholar
• Barthez MA, Araujo E, Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J. Child Neurol.15(3), 150–156 (2000).
   PubMed Web of Science ®Google Scholar
• Makras P, Samara C, Antoniou M et al. Evolving radiological features of hypothalamo–pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology48(1), 37–44 (2006).
   Google Scholar
• Kaltsas GA, Powles TB, Evanson J et al. Hypothalamo–pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J. Clin. Endocrinol. Metab.85(4), 1370–1376 (2000).
   PubMed Web of Science ®Google Scholar
• Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans’ cell histiocytosis. Clin. Endocrinol. (Oxford)53(4), 509–515 (2000).
   Google Scholar
• Donadieu J, Rolon MA, Thomas C et al. Endocrine involvement in pediatric-onset Langerhans’ cell histiocytosis: a population-based study. J. Pediatr.144(3), 344–350 (2004).
   PubMed Web of Science ®Google Scholar
• Grois N, Prayer D, Prosch H, Minkov M, Potschger U, Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr. Blood Cancer43(1), 59–65 (2004).
   PubMedGoogle Scholar
• Prosch H, Grois N, Prayer D et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr. Blood Cancer43(5), 594–599 (2004).
   PubMedGoogle Scholar
• Maghnie M, Sommaruga MG, Beluffi G, Severi F. Role of MR imaging in the evaluation of the functional status of the posterior pituitary gland: the view of a pediatric endocrinologist. AJNR Am. J. Neuroradiol.14(6), 1443–1445 (1993).
   PubMed Web of Science ®Google Scholar
• Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer85(10), 2278–2290 (1999).
   PubMed Web of Science ®Google Scholar
• Grois N, Potschger U, Prosch H et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr. Blood Cancer46(2), 228–233 (2006).
   PubMed Web of Science ®Google Scholar
• Maghnie M, Cosi G, Genovese E et al. Central diabetes insipidus in children and young adults. N. Engl. J. Med.343(14), 998–1007 (2000).
   PubMed Web of Science ®Google Scholar
• Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer76(12), 2471–2484 (1995).
   PubMed Web of Science ®Google Scholar
• Donadieu J, Rolon MA, Pion I et al. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J. Clin. Endocrinol. Metab.89(2), 604–609 (2004).
   PubMed Web of Science ®Google Scholar
• Makras P, Papadogias D, Kontogeorgos G, Piaditis G, Kaltsas GA. Spontaneous gonadotrophin deficiency recovery in an adult patient with Langerhans cell histiocytosis (LCH). Pituitary8(2), 169–174 (2005).
   Google Scholar
• Modan-Moses D, Weintraub M, Meyerovitch J, Segal-Lieberman G, Bielora B. Hypopituitarism in Langerhans cell histiocytosis: seven cases and literature review. J. Endocrinol. Invest.24(8), 612–617 (2001).
   Google Scholar
• Larsen R, Kronenberg H, Melmed S, Polonsky K. Williams Textbook of Endocrinology (10th Edition). Saunders, USA (2003).
   Google Scholar
• Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med. Pediatr. Oncol.24(4), 248–256 (1995).
   PubMedGoogle Scholar
• Thompson LD, Wenig BM, Adair CF, Smith BC, Heffess CS. Langerhans cell histiocytosis of the thyroid: a series of seven cases and a review of the literature. Mod. Pathol.9(2), 145–149 (1996).
   Google Scholar
• Yap WM, Chuah KL, Tan PH. Langerhans cell histiocytosis involving the thyroid and parathyroid glands. Mod. Pathol.14(2), 111–115 (2001).
   Google Scholar
• Coode PE, Shaikh MU. Histiocytosis X of the thyroid masquerading as thyroid carcinoma. Hum. Pathol.19(2), 239–241 (1988).
   Google Scholar
• Kitahama S, Iitaka M, Shimizu T et al. Thyroid involvement by malignant histiocytosis of Langerhans’ cell type. Clin. Endocrinol. (Oxford)45(3), 357–363 (1996).
   Google Scholar
• Axiotis CA, Merino MJ, Duray PH. Langerhans cell histiocytosis of the female genital tract. Cancer67(6), 1650–1660 (1991).
   PubMed Web of Science ®Google Scholar
• Miller AA, Ramsden F. Neural and visceral xanthomatosis in adults. J. Clin. Pathol.18(5), 622–635 (1965).
   Google Scholar
• Goyal R, Das A, Nijhawan R, Bansal D, Marwaha RK. Langerhans cell histiocytosis infiltration into pancreas and kidney. Pediatr. Blood Cancer49(5), 748–750 (2006).
   Google Scholar
• Ben GI, Houman MH, B’chir S, Chamakhi S, Miled M. [A disseminated form of Langerhans histiocytosis associated with diabetes insipidus and diabetes mellitus]. Rev. Med. Interne22(5), 469–474 (2001).
   Google Scholar
• Trochtenberg DS, Dessypris EN. Reversible hepatomegaly and diabetes mellitus in an adult with disseminated histiocytosis X. Am. J. Med. Sci.299(3), 179–184 (1990).
   Google Scholar
• Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann. Intern. Med.141(10), 764–770 (2004).
   PubMed Web of Science ®Google Scholar
• Alexander RW. Inflammation and coronary artery disease. N. Engl. J. Med.331(7), 468–469 (1994).
   PubMed Web of Science ®Google Scholar
• Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet336(8710), 285–288 (1990).
   PubMed Web of Science ®Google Scholar
• Ladisch S, Gadner H, Arico M et al. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Med. Pediatr. Oncol.23(2), 107–110 (1994).
   PubMedGoogle Scholar
• Bernard F, Thomas C, Bertrand Y et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur. J. Cancer41(17), 2682–2689 (2005).
   PubMed Web of Science ®Google Scholar
• Dhall G, Finlay JL, Dunkel IJ et al. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Pediatr. Blood Cancer (2007) (Epub ahead of print).
   Google Scholar
• Pardanani A, Phyliky RL, Li CY, Tefferi A. 2-chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin. Proc.78(3), 301–306 (2003).
   PubMed Web of Science ®Google Scholar
• Farran RP, Zaretski E, Egeler RM. Treatment of Langerhans cell histiocytosis with pamidronate. J. Pediatr. Hematol. Oncol.23(1), 54–56 (2001).
   PubMedGoogle Scholar
• Minkov M, Grois N, Broadbent V, Ceci A, Jakobson A, Ladisch S. Cyclosporine A therapy for multisystem langerhans cell histiocytosis. Med. Pediatr. Oncol.33(5), 482–485 (1999).
   PubMedGoogle Scholar
• Lukina EA, Kuznetsov VP, Beliaev DL, Kaplanskaia IB, Mokeeva RA. [The treatment of histiocytosis X (Langerhans-cell histiocytosis) with α-interferon preparations]. Ter. Arkh.65(11), 67–70 (1993).
   Google Scholar
• Reichle A, Vogt T, Kunz-Schughart L et al. Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans’ cell histiocytosis of adults. Br. J. Haematol.128(5), 730–732 (2005).
   PubMed Web of Science ®Google Scholar
• Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation. Chest115(5), 1452–1455 (1999).
   Web of Science ®Google Scholar
• Dauriat G, Mal H, Thabut G et al. Lung transplantation for pulmonary langerhans’ cell histiocytosis: a multicenter analysis. Transplantation81(5), 746–750 (2006).
   PubMed Web of Science ®Google Scholar
• Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J. Pediatr. Hematol. Oncol.23(9), 629–632 (2001).
   PubMed Web of Science ®Google Scholar
• Akkari V, Donadieu J, Piguet C et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant.31(12), 1097–1103 (2003).
   PubMedGoogle Scholar
• Tatevossian R, Nanduri V, Salotti J et al. Adults with LCH – orphans with an orphan disease. Clin. Med.6(4), 404–408 (2006).
   PubMed Web of Science ®Google Scholar